Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Correlative Study of Denosumab Effects on Tissue and Imaging Breast Biomarkers

NCT02613416 is registered in ClinicalTrials.gov with Alison Stopeck as lead sponsor.

NCT NCT02613416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02613416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Correlative Study of Denosumab Effects on Tissue and Imaging Breast Biomarkers
Lead sponsor
Alison Stopeck
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2015
Completion date
August 20, 2021
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer